Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Carr

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Cancer|December 1, 1976
Combination chemotherapy of advanced lung cancer: a randomized trialH H Hansen, O S Selawry, R Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancerH M Dhingra, M Valdivieso, D T Carr, et al.
Cancer Treatment Reports|June 1, 1986
Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinomaD F Chiuten, D T Carr, H M Dhingra, et al.
Cancer Treatment Reports|July 1, 1985
Phase II clinical trial of diaziquone in bronchogenic carcinomaD F Chiuten, T Umsawasdi, H M Dhingra, et al.
Cancer Treatment Reports|October 1, 1977
Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancerR T Eagan, J N Ingle, S Frytak, et al.
Investigational New Drugs|September 1, 1988
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinomaP Y Holoye, D T Carr, H M Dhingra, et al.
American Journal of Clinical Oncology|October 1, 1984
Prospective evaluation of thymosin fraction V immunotherapy in patients with non-small cell lung cancer receiving vindesine, doxorubicin, and cisplatin (VAP) chemotherapyA Y Bedikian, Y Z Patt, W K Murphy, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1988
Combined chemoradiotherapy in limited-disease, inoperable non-small cell lung cancerT Umsawasdi, M Valdivieso, H T Barkley, et al.
Texas Medicine|August 1, 1984
Increasing importance of adjuvant surgery in inoperable lung cancerM Valdivieso, P Farha, M J McMurtrey, et al.
Cancer|June 15, 1987
Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1F Laberge, H A Fritsche, T Umsawasdi, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Cancer|December 1, 1976
Combination chemotherapy of advanced lung cancer: a randomized trialH H Hansen, O S Selawry, R Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancerH M Dhingra, M Valdivieso, D T Carr, et al.
Cancer Treatment Reports|June 1, 1986
Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinomaD F Chiuten, D T Carr, H M Dhingra, et al.
Cancer Treatment Reports|July 1, 1985
Phase II clinical trial of diaziquone in bronchogenic carcinomaD F Chiuten, T Umsawasdi, H M Dhingra, et al.
Cancer Treatment Reports|October 1, 1977
Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancerR T Eagan, J N Ingle, S Frytak, et al.
Investigational New Drugs|September 1, 1988
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinomaP Y Holoye, D T Carr, H M Dhingra, et al.
American Journal of Clinical Oncology|October 1, 1984
Prospective evaluation of thymosin fraction V immunotherapy in patients with non-small cell lung cancer receiving vindesine, doxorubicin, and cisplatin (VAP) chemotherapyA Y Bedikian, Y Z Patt, W K Murphy, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1988
Combined chemoradiotherapy in limited-disease, inoperable non-small cell lung cancerT Umsawasdi, M Valdivieso, H T Barkley, et al.
Texas Medicine|August 1, 1984
Increasing importance of adjuvant surgery in inoperable lung cancerM Valdivieso, P Farha, M J McMurtrey, et al.
Cancer|June 15, 1987
Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1F Laberge, H A Fritsche, T Umsawasdi, et al.
Pageof 7